Aromatase and regulation of bone remodeling

Joint Bone Spine

Volumn 73, Issue 1, 2006, Pages 37-42

  Ribot, Claude ^a   Trémollieres, Florence ^a   Pouillés, Jean Michel ^a  

^a Paul Sabatier University   (France)

Author keywords

Aromatase; Bone remodeling; Estrogens; Osteoporosis

Indexed keywords

ANASTROZOLE; AROMATASE; AROMATASE INHIBITOR; CORTICOSTEROID; CYTOCHROME P450; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; TAMOXIFEN;

AROMATIZATION; BONE MINERALIZATION; BONE REMODELING; BONE TISSUE; BREAST CANCER; ENZYME ACTIVITY; ENZYME DEFICIENCY; ESTROGEN RELEASE; ESTROGEN SYNTHESIS; HUMAN; MENOPAUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OVARY; POSTMENOPAUSE; PROTEIN EXPRESSION; REVIEW;

EID: 32044475199     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2005.02.005     Document Type: Short Survey

References (55)

1. R.L. Jilka, G. Hangoc, G. Girasole, G. Passeri, C.D. Williams, and J.S. Abrams Increased osteoclast development after estrogen loss: mediation by interleukin-6 Science 257 1992 88 92
2. M.C. Horrowitz Cytokines and estrogen in bone: anti-osteoporotic effects Science 260 1993 626 627
3. C. Ribot, and F. Tremollieres Effect of estrogens on bone and others systems and hormonal substitute treatment Curr. Opin. Orthop. 8 1997 45 52
4. S.C. Manalogas, S. Kousteni, and R.L. Jilka Sex steroids and bone Rec. Progress Hormon Res. 57 2002 385 409
5. B.S. Komm, C. Terpening, D.J. Benz, K.A. Graeme, A. Gallegos, and M. Korc Estrogen binding, receptor mRNA and biological responses in osteoblast-like osteosarcoma cells Science 241 2002 81 83
6. E.F. Eriksen, D.S. Colvard, N.J. Berg, M.L. Graham, K.G. Mann, and T.C. Splesberg Evidence of estrogen receptors in normal human osteoblast-like cells Science 241 1988 84 86
7. S. Bord, A. Horner, S. Beavan, and J. Compston Estrogen receptors alpha and beta are differentially expressed in developing human bone J. Clin. Endocrinol. Metab. 86 2001 2309 2314
8. D.S. Colvard, E.F. Eriksen, P. Keeting, E.M. Wilson, D.B. Luban, and F.S. French Identification of androgen receptors in normal human osteoblast-like cells Proc. Natl. Acad. Sci. USA 86 1989 854 857
9. L.J. Eyre, R. Bland, I.J. Bujalska, M.C. Sheppard, P.M. Stewart, and M. Hewison Characterization of aromatase and 17β-hydroxysteroid dehydrogenase expression in rat osteoblastic cells J. Bone Miner. Res. 13 1998 996 1004
10. Y. Dong, Q.Q. Qiu, J. Debaer, W.F. Lathrop, D.R. Bertolini, and P.P. Tamburini 17-Beta-hydroxysteroid dehydrogenase in human bone cells J. Bone Miner. Res. 13 1998 1539 1546
11. Y. Ishida, D.W. Killinger, M.W. Khalil, K. Yang, B. Strutt, and J.N.M. Heersche Expression of steroid-converting enzymes in osteoblasts derived from rat vertebrae Osteoporos. Int. 13 2002 235 240
12. H. Fujikawa, F. Okura, Y. Kuwano, A. Sekizawa, H. Chiba, and K. Shimodaira Steroid sulfatase activity in osteoblast cells Biochem. Biophys. Res. Commun. 231 1997 42 47
13. K. Shimodaira, H. Fujikawa, F. Okura, Y. Shimizu, H. Saito, and T. Yanaihara Osteoblast cells (MG-63 and HOS) have aromatase and 5alpha-reductase activities Biochem. Mol. Bio. Int. 39 1996 109 116
14. S. Issa, D. Schnabel, M. Feix, L. Wolf, H.E. Schaefer, and D.W. Russell Human osteoblast-like cells express predominantly steroid-5α-reductase type 1 J. Clin. Endocrinol. Metab. 87 2002 5401 5407
15. E.R. Simpson, M.S. Mahendroo, G.D. Means, M.W. Kilgore, M.M. Hinshelwood, and S. Graham-Lorence Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis Endocr. Rev. 15 1994 342 355
16. S. Chen, Y.C. Kao, and C.A. Laughton Binding characteristics of aromatase inhibitors and phytoestrogens to aromatase J. Steroid Biochem. Biol. Mol. 44 1997 389 397
17. Y.C. Kao, K.R. Korzekwa, C.A. Laughton, and S. Chen Evaluation of the mechanism of aromatase P450 Eur. J. Biochem. 2001 243 251
18. K. Toda, E.R. Simpson, C.R. Mendelson, Y. Shizuta, and M.W. Kilgore Expression of the gene encoding aromatase cytochrome P450 (CYP19) in fetal tissues Mol. Cel. Endocrinol. 8 1994 210 217
19. S.E. Bulun, S. Yang, Z. Fang, B. Gurates, M. Tamura, and J. Zhou Role of aromatase in endometrial disease J. Steroid Biochem. Mol. Biol. 9 2001 19 25
20. S.E. Bulun, E.R. Simpson, and R.A. Word Expression or the CYP19 gene and its product aromatase cytochrome P450 in human uterine leiomyoma tissues and cells in culture J. Clin. Endocrinol. Metab. 78 1994 736 743
21. Brodie A, Nakamura J. Aromatase in the normal breast and breast cancer. J. Steroid Biochem. Mol. Biol. 61: 281-6.
22. S. Chen, D. Zhou, C. Yang, T. Okubo, Y. Kinoshita, and B. Yu Modulation of aromatase expression in human breast tissue J. Steroid Biochem. Mol. Biol. 79 2001 35 40
23. S. Chen, M.J. Besman, R.S. Sparkes, S. Zollman, I. Klisak, and T. Mohandas Human aromatase: cDNA cloning, southern blot analysis, and assignment of the gene to chromosome 15 DNA 7 1988 27 38
24. G.D. Means, M.S. Mahendroo, C.J. Corbin, J.M. Mathis, F.E. Powell, and C.R. Mendelson Structural analysis of the gene encoding human aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis J. Biol. Chem. 19 1989 385 391
25. S. Sebastian, and S.E. Bulun A highly complex organization of the regulatory region of the human CYP19 (aromatase) gene revealed by the human genome project J. Clin. Endocrinol. Metab. 86 2002 4600 4602
26. M. Shozu, H. Sumitani, T. Segawa, H.J. Yang, K. Muraakami, and T. Kasai Overexpression of aromatase P450 in leiomyoma tissue is driven primarily through promoter I.4 of the aromatase P450 gene (CYP19) J. Clin. Endocrinol. Metab. 87 2002 2540 2548
27. T. Suzuki, T. Morya, T. Ishida, M. Kimura, N. Ohuchi, and H. Sasano In situ production of estrogens in human breast carcinoma Breast Cancer 9 2002 296 302
28. H. Nawata, S. Tanaka, R. Takayangi, Y. Sakai, T. Yanase, and S. Ikuyama Aromatase in bone cell. Association with osteoporosis in post menopausal women J. Steroid Biochem. Mol. Bio. 53 1995 165 174
29. H. Sasano, T. Sawai, H. Nagura, G. Matsunaga, and O. Kashimoto Aromatase in human bone tissue J. Bone Miner. Res. 12 1997 1416 1423
30. M. Shozu, and E.R. Simpson Aromatase expression of human osteoblast-like cells Mol. Cell Endocrinol. 139 1998 117 129
31. C.K. Lea, H. Ebrahim, S. Tennant, and A.M. Flangan Aromatase cytochrome P450 transcripts are detected in fractured human bone but not in normal skeletal tissue Bone 21 1997 433 440
32. S. Tanaka, M. Haji, R. Takayanagi, and H. Nawata 1,25-Dihydroxyvitamin D3 enhances the enzymatic activity and expression of the messenger ribonucleic acid for aromatase cytochrome P450 synergistically with dexametazone depending on the vitamin D receptor level in cultured human osteoblasts Endocrinology 137 1996 1860 1869
33. M. Morioka, K. Shimodaira, Y. Kuwano, H. Fujikawa, H. Saito, and T. Yanahaira Effect of interleukin-1β on aromatase activity and cell proliferation in human osteoblast-like cell Biochem. Biophys. Res. Commun. 268 2000 60 64
34. M. Shozu, Y. Zhao, and E.R. Simpson TGF-β1 stimulates expression of the aromatase (CYP19) gene in human osteoblast-like cells and in THP-1 cells Mol. Cell. Endocrinol. 160 2000 123 133
35. M. Shozu, H. Sumitani, K. Murakami, T. Segawa, H.J. Yang, and M. Inoue Regulation of aromatase activity in bone-derived cells: possible role of mitogen-activated protein kinase J. Steroid Biochem. Mol. Bio. 79 2001 61 65
36. C. Miyaura, K. Toda, M. Inada, T. Ohshiba, C. Matsumoto, and T. Okada Sex- and age-related response to aromatase deficiency in bone Bioch. Biophys. Res. Com. 280 2001 1062 1068
37. O.K. Öz, G. Hirasawwa, J. Lawson, L. Nanu, A. Constantinescu, and P.P. Antich Bone phenotype of the aromatase deficient mouse J. Ster. Biochem. Mol. Biol. 79 2001 49 59
38. A. Morishima, M.M. Grumbach, E.R. Simpson, C. Fisher, and K. Qin Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens J. Clin. Endocrinol. Metab. 80 1995 3689 3698
39. C. Carani, K. Qin, and M. Simoni Effect of testosterone and estradiol in a man with aromatase deficiency N. Engl. J. Med. 337 1997 91 95
40. J.P. Bilezikian, A. Morishima, J. Bell, and M. Gumbach Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency N. Engl. J. Med. 9 1998 599 603
41. E.C. Smith, J. Boyd, G.R. Frank, H. Takahashi, R.M. Cohen, and B. Specker Estrogen resistance caused by a mutation in the estrogen-receptor in a man N. Engl. J. Med. 331 1994 1056 1061
42. D. Vanderschueren, S. Boonen, A.G. Ederveen, R. de Coster, E. Van Herck, and K. Moermans Skeletal effect of estrogen deficiency as induced by an aromatase inhibitor in an aged male rat model Bone 27 2000 611 617
43. J. Somner, S. McLellan, J. Cheung, Y.T. Mak, M.L. Frost, and K.M. Knapp Polymorphisms in the P450 c17 (17-hydroxylase/17,20-Lyase) and P450 c19 (aromatase) genes: association with serum sex steroid concentrations and bone mineral density in postmenopausal women J. Clin. Endocrinol. Metab. 89 2004 344 351
44. M.T. Zarrabeita, J. Hernandez, C. Valero, A.L. Zarrabeita, M. Garcia-Unzueta, and J.A. Amado A common polymorphism in the 5′ untranslated region or the aromatase gene influences bone mass and fracture risk Eur J. Endocrinol. 150 2004 699 704
45. E. Bajetta, A. Martinetti, N. Zilembo, P. Pozzi, I. La Torre, and L. Ferrari Biological activity of astronazole in postmenopausal patients with advanced breast cancer: effects on estrogens and bone metabolism Ann. Oncol. 13 2002 1059 1066
46. M. Baum, A.U. Budzar, J. Cuzick, J. Forbes, J.H. Houghton, and J.G. Klijn Anastrazole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomized trail Lancet 359 2002 2131 2139
47. S.E. Bulun, L.S. Noble, K. Takayama, M. Dodson Michael, V. Agarwal, and C. Fisher Endocrine disorders associated with inappropriately high aromatase expression J. Steroid Biochem. Mol. Biol. 61 1997 133 139
48. C.A. Stratakis, A. Votero, A. Brodie, L.S. Kirschner, D. DeAtkine, and Q. Lu The aromatase excess syndrome is associated with feminization of both sexes and autosomal dominant transmission of aberrant P450 aromatase gene transcription J. Clin. Endocrinol. Metab. 83 1998 1348 1357
49. S.E. Bulun, B. Gurates, Z. Fang, M. Tamura, S. Sebastian, and J. Zhou Mechanisms of excessive estrogen formation in endometriosis J. Reprod. Immunol. 55 2002 21 33
50. J.A. Cauley, F.L. Lucas, L.H. Kuller, T.M. Vogt, W.S. Browner, and S.R. Cummings Bone mineral density and risk of breast cancer in older women: the Study of Osteoporotic Fractures JAMA 276 1996 1404 1408
51. Y. Zang, D. Kiel, B. Kreger, L.A. Cupples, R.C. Allison, and J.F. Dorgan Bone mass and the risk of breast cancer among postmenopausal women N. Engl. J. Med. 336 1997 611 617
52. J.M. Zmuda, J.A. Cauley, B.M. Ljung, D.C. Bauer, and S.R. Cummings The Study of Osteoporotic Fracture Research Group. Bone mass and breast cancer risk in older women: difference stage at diagnosis J. Natl. Cancer Inst. 93 2001 930 936
53. D.S. Buis, A.Z. LaCroix, W.E. Barlo, E. White, J.A. Cauley, and D.C. Bauer Bone mineral density and endogenous hormones and risk of cancer in postmenopausal women Cancer Causes Control 12 2001 213 222
54. L. Masi, L. Becherini, L. Gennari, A. Amedei, E. Colli, and A. Falchetti Polymorphism of the aromatase gene in postmenopausal Italian women: distribution and correlation with bone mass and fracture risk J. Clin. Endocrinol. Metab. 86 2001 2263 2269
55. Y. Miyoshi, A. Ando, S. Hasegawa, M. Ishitobi, J. Yamamura, and N. Irahara Association of genetic polymorphisms in CYP19 and CYP1A1 with the estrogen receptor-positive cancer risk Eur. J. Cancer 39 2003 2531 2537